Abstract: Birt-Hogg-Dube´(BHD) syndrome is an autosomal dominant disorder characterized by fibrofolliculomas, renal tumors, and pulmonary cysts with recurrent pneumothorax. Multiple pulmonary cysts and pneumothorax are the key signs for diagnosing BHD syndrome. The pathologic features of BHD pulmonary cysts, however, are poorly understood. This disorder is caused by mutations in the gene that encodes folliculin (FLCN). FLCN is regarded as a tumor suppressor; it mediates cellular activities by interacting with the mammalian target of rapamycin (mTOR). In this study, we investigated the lungs of 11 patients from 9 BHD families. The majority of patients consulting doctors were women between 30 and 60 years of age who had pulmonary cysts and repeated pneumothoraces. Genomic DNA testing revealed 5 different mutation patterns. Histopathologic examination found that the inner surface of cysts was lined by epithelial cells, sometimes with a predominance of type II pneumocyte-like cuboidal cells. The cysts occasionally contained internal septa consisting of alveolar walls or showed an "alveoli within an alveolus" pattern. The cells constituting the cysts stained positive for phospho-S6 ribosomal protein expression, suggesting activation of the mTOR pathway. Although BHD pulmonary cysts are frequently misdiagnosed as nonspecific cystic diseases, they are distinctly different in histopathology from other bullous changes. Mechanical stress such as rupture and postrupture remodeling allows mesothelial invagination and fibrosis. Such modified BHD pulmonary cysts are virtually indistinguishable from nonspecific blebs and bullae. We propose a new insight, namely, that the BHD syndrome-associated pulmonary cyst may be considered a hamartoma-like cystic alveolar formation associated with deranged mTOR signaling.
T he Birt-Hogg-Dube´(BHD) syndrome is an inherited disorder caused by mutation in the folliculin (FLCN) gene located on chromosome 17p11.2. 19 FLCN consists of 14 exons, and it encodes the protein folliculin (FLCN). 19 Among characteristic BHD presentations such as pneumothorax and fibrofolliculomas, renal tumor is the most serious manifestation with regard to prognosis. BHD syndrome-associated disorders generally occur in adulthood. Renal tumors are diagnosed at ages ranging from 40 to 70 years, which are older than when pulmonary cysts affect patients, which is at around 20 to 30 years of age. 15, 32 Therefore, pneumothorax-induced dyspnea and chest pain are clinically important symptoms that allow the patient to undergo thorough medical examination and obtain early detection of renal tumors. 28 We have recently reported the pathologic findings from the lung of a patient who had no family history of pneumothorax, and we demonstrated that the pathology of pulmonary cysts contributed greatly to the diagnosis of BHD syndrome.
14 These cysts are lined by epithelial cells that on the inner surface of the cyst stain positively for surfactant protein A (SP-A), prosurfactant protein C (proSP-C), and thyroid transcription factor 1 (TTF-1) 14 and are distinguishable from blebs and bullae. Together with the radiologic finding that multiple cysts are localized preferentially in lower lobes, 7 the distinctive histopathologic features of the resected cysts provide important diagnostic clues. Nevertheless, the pulmonary cysts of BHD syndrome have frequently been confused with other bullous diseases and spontaneous pneumothorax. 5, 6, 22 Limited, inaccurate information on the pulmonary pathology associated with BHD syndrome makes correct diagnosis of pulmonary cysts difficult. Furthermore, the walls of cysts are frequently modified by secondary changes associated with recurrent pneumothorax, and some cysts may be indistinguishable from blebs and bullae. Detailed pathologic studies of BHD lungs from several cases have not been reported yet.
Intensive studies on the genetic dysfunction of FLCN have improved our understanding of the molecular basis of this disorder, which is associated with the dysregulated mammalian target of rapamycin (mTOR) pathway. 3 It is known that FLCN forms a complex with its binding proteins, folliculin-interacting protein (FNIP)1 and FNIP2/ FNIPL, and that the complex interacts with 5 0 -AMPactivated protein kinase (AMPK). 9, 24 As a molecule linking AMPK and mTOR complex 1 (mTORC1), FLCN may be compared with hamartin (TSC1) and tuberin (TSC2). Mutations in TSC1 or TSC2 lead to the systemic disorder tuberous sclerosis. 12 In contrast to the distinctive role of the TSC1-TSC2 complex, which negatively regulates mTORC1, the actual role of FLCN in human pathology has not yet been fully determined. Some studies have revealed an inhibitory effect of FLCN on mTORC1, such that kidney-directed FLCN gene inactivation resulted in multiple renal cysts with accelerated mTOR signaling. 2, 9, 10 In contrast, other studies have demonstrated that FLCN gene knockdown leads to reduced phosphorylation of ribosomal protein S6, suggesting that FLCN might stimulate downstream of mTORC1. 8, 24 The function of FLCN in mTOR signaling seems to be context dependent. 11 In human BHD, little is known about the role of FLCN in lung pathophysiology. The association between the development of pulmonary cysts and the regulation of the mTOR pathway has not been determined yet.
In this study, we performed genomic DNA analysis and investigated detailed microscopic features of BHD lungs. We identified 5 mutation patterns. Three were the same as those reported in Japanese but not in western BHD families. 7, 15 Little is known of the prevalence of BHD syndrome in Asian countries. An increase in the numbers of case reports over the past 5 years indicates that there remain many undiagnosed BHD families. The current histologic and immunohistochemical studies of BHD syndrome elucidate the hamartoma-like nature of the pulmonary cysts, in which mTOR signaling is subtly activated under FLCN haploinsufficiency.
MATERIALS AND METHODS

Samples
Twenty-two patients from 9 families (F1 to F9) were enrolled in this study (Table 1) . Written informed consent for analysis of the FLCN gene was obtained from the 
DNA Isolation
DNA from peripheral blood leukocytes was obtained using LabPass Blood Mini kits (Cosmo GENETECH, Seoul, Korea) according to the manufacturer's instructions.
Direct Sequencing
Fourteen exons of the FLCN gene were amplified by polymerase chain recation (PCR) using primers described previously. 19 The conditions for PCR were described in a previous study.
14 After purification, DNA was labeled using the BigDye Terminator v1.1 Cycle Sequencing Kits (Applied Biosystems, Cleveland, OH), and DNA sequencing was performed using the ABI Prism 3100 Genetic Analyzer (Applied Biosystems). The PCR products from presumptive regions of nucleotide alterations were subcloned (TA Cloning Kit, Invitrogen, San Diego, CA) and then sequenced to clarify the mutation patterns.
Western Blotting
A volume of 12.5 mg of each protein lysate of the kidney (case 8, F4) was separated on SDS-PAGE and transferred to a PVDF membrane (Millipore). For detection of p-mTOR bands, 7.5% gels were used, and for detection of other molecules 12.5% gels were used. The antibodies against FLCN, p-S6 (Ser 235/236), and p-mTOR (Ser 2448) were the same as those used in immunohistochemical studies. Mouse monoclonal antibody against b-actin was purchased from Sigma (St. Louis, MO). Horseradish peroxidase-conjugated goat anti-rabbit IgG and anti-mouse IgG (Santa Cruz Biotechnology) were used as secondary antibodies. Bands were detected using an enhanced chemiluminescence system, according to the Hybond ECL protocol (GE Healthcare, Buckinghamshire, UK).
RESULTS
Clinical Histories and FLCN Gene Mutation Patterns of Affected Families
The clinical information on 22 individuals from 9 families (F1 to F9) is summarized in Table 1 and Figure 1 . F5 was Taiwanese, and the other 8 families were Japanese. In 7 of 9 families (F1 to F3, F5 to F8), repeated pneumothorax triggered comprehensive medical examinations of the affected members. Six patients were middleaged women with histories of repeated pneumothoraces. In the other 2 families (F4, F9), histopathologic findings of renal tumors led the pathologists to consider BHD syndrome. Although the family members of F4 did not develop pneumothorax, thoracic computed tomography (CT) revealed that affected members (cases 7 and 8) had multiple pulmonary cysts.
Clinical data revealed that pulmonary cysts occurred most frequently, with 100% penetrance; they were seen in all the patients (n = 11) who underwent thoracic CT. Among these patients, 1 (case 16) had smoked cigarettes from 19 to 35 years of age, and another (case 21) had been a smoker for 45 years. The others were nonsmokers.
Fibrofolliculomas were found in 7 individuals (Figs. 2C, D) ; however, none of these patients or the screening physicians noticed that their skin tumors were manifestations of BHD syndrome. A patient (case 7) in 1 family (F4) was diagnosed with renal tumor and underwent right total nephrectomy. After an FLCN gene mutation was detected, members of her family underwent medical examinations, and her daughter (case 8) was found to have an early-stage renal tumor. The daughter underwent nephron-sparing surgery and has been well for 15 months. Among 9 families, 3 patients who consulted doctors did not have significant family histories, but it was later revealed that a few members of the families also had fibrofolliculomas on the face and neck, or latent pulmonary cysts (F1, F4, and F7). Characteristic pathologic features of the lungs or kidneys alerted us to the possibility of BHD syndrome-associated disorders, and additional examinations and genetic tests resulted in correct diagnoses and findings in the other affected family members.
Five heterozygous mutation patterns ( Fig. 1 and Supplemental Digital Content 1, http://links.lww.com/PAS/ A111) were identified in the 8 examined families (the DNA analysis of F6 was performed elsewhere). F1 showed aberrant sequence repeats (2 to 3 times) of 7 nucleotides (CCACCCT). F2 showed reduced repeats of 2 nucleotides (TC) from 3 to 2 times. F3 and F9 showed an increase in cytosine repeats from 8 (C) 8 to 9 times (C) 9 . These 2 patients (cases 5 and 21) were diagnosed with renal tumors. F4, F5, and F7 showed the following mutation pattern that had not been reported in other groups: a deletion of 18 base pairs in exon 5 (c.332_349del), which contained 7 nucleotide (CCCCAGC) repeats. In addition, an insertion of 7 nucleotides in exon 12 of F1 (c.1347_1353dupCCCACCCT) and a deletion of 4 base pairs in exon 13 of F8 (c.1533_1536delGATG) had only been reported in Japanese patients 7, 15 but not in North American and European BHD families. 31 The results suggest
TT-(CCACCCT) 2 -GT AG-(TC) 3 -AG
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[9]
[10] that the gene mutation hot spots in FLCN may be different between Asian and Western pedigrees.
Pathologic Features of Pulmonary Cysts
All 11 patients who underwent thoracic CT were found to have multiple pulmonary cysts. Among them, 8 lung specimens were obtained from pulmonary wedge resections and used for histologic analysis. The lung tissues did not contain any other pathologic lesions. The histopathologic findings in the lung specimen from case 1 (F1) were described in our previous report. 14 In the other 7 cases, the resected pulmonary specimens had several cysts. The cysts were multifocally localized in >1 lobe (Figs. 2A, B) . Microscopically, the walls of the cysts were partially incorporated with interstitial stroma of the interlobular septum, visceral pleura, or bronchovascular bundle (Fig. 3A) . The inner surfaces of the cysts were lined with cytokeratin-positive monolayer cells, 14 which were positively stained for proSP-C (Figs. 3B-D) , SP-A, and TTF-1 expression (data not shown). These results suggest that the cyst-lining cells are differentiated pneumocytes and that the histopathology of these cysts is distinctly different from that of nonspecific blebs or bullae. These epithelial cells were often attenuated or partly invisible. Neoplastic proliferation was not evident in these cysts; however, type II pneumocyte-like cuboidal cells were frequently observed on the inner and outer surfaces (Fig. 3B) . These cyst-lining cuboidal cells and the alveolar cells surrounding the cyst were occasionally positive for PCNA expression (Figs. 3E, F) . In areas lined with several adjacent cuboidal cells, at least a few PCNA-positive cells were observed. In addition, b-catenin immunostaining of these cells exhibited nuclear and/or cytoplasmic patterns (data not shown). Blebs/bullae-like inflammation was not seen in the parenchyma surrounding these cysts, but ruptured walls of cysts showed fibrotic thickening (Fig. 4A) . In 1 patient (case 11), only fibrotic visceral pleurae in which mesothelial cells had invaginated were resected (Figs. 4B, C) . Similarly, the pulmonary specimens from most cases had thickened visceral pleurae with bleb-like airspaces and fibrosis. With close examination, however, we found unique features such as a few alveolus-like structures formed within the cyst (Fig. 4D) and giant alveoli incorporated with stroma (inset in Fig. 3A and Koga et al 14 )
. These findings suggest that microscopic features of the lung in BHD syndrome are distinguishable from other airspace diseases and that the cyst-lining epithelial cells may be mildly activated. We hypothesized that the signaling pathway involved with cell survival or proliferation might be stimulated when there is FLCN haploinsufficiency.
Expression of FLCN and mTOR Signaling Molecules in BHD Lungs and Kidneys
In our previous study of case 1, both normal-looking parenchymal pneumocytes and cyst-lining epithelial cells were positively immunostained for FLCN. 14 In the current study, we performed FLCN immunostaining on the other resected BHD tissues. In all examined cases, the epithelial cells in the pulmonary cysts stained positive for FLCN expression (Figs. 5A, B) , suggesting that FLCN exists in a haploinsufficient form in cyst-lining epithelial cells.
Next, we examined expression of mTORC1 in BHD lungs. In cyst-lining epithelial cells, p-mTOR (Ser 2448) was weakly expressed (Fig. 5C) , and p-S6 (Ser 235/236) was strongly expressed (Fig. 5D) . In normal lungs (n = 4) and blebs/bullae (n = 5), the expression of these proteins was generally negative in quiescent parenchyma (Figs. 5E,  F ). There were areas of focal positivity in the subpleural area of normal lungs and in the fibrotic walls of blebs/ bullae (data not shown).
To determine whether FLCN is expressed in solid neoplasms from BHD patients, we examined 3 renal tumors (cases 5, 7, and 8). In cases 5 and 7, the resected kidney contained a few tumor masses. In case 8, the tumor nodule was 2 cm in diameter, and nephron-sparing surgery was performed. These tumors displayed hybrid oncocytic/chromophobe features. In areas free of tumor, small nodules of renal oncocytosis were detected. These (Figs. 6A, B) . We observed that the resected kidneys had several cystic lesions in tumorfree regions (Figs. 6C, D) . Multispaced cysts with plump epithelial cells were unlikely to represent atrophic degeneration; the morphology was reminiscent of doublespaced pulmonary cysts (Fig. 4D and Koga et al  14 ) . The cyst-lining cells were clearly positively stained for FLCN expression (Fig. 6E) . The results suggest different FLCN conditions in cystic lesions and solid tumor nests. On Western blotting analysis, the FLCN band was detectable in normal-looking renal tissue samples, whereas the band was almost undetectable in BHD tumor samples (Fig. 6F) . The intensities of p-mTOR and p-S6 (Ser 235/ 236) bands were increased in BHD kidney specimens. The p-S6 band of tumor specimens stained strongest. In solid tumor nests, FLCN is likely to be significantly suppressed, and the mTOR pathway is no longer under physiological regulation.
DISCUSSION
Spontaneous pneumothorax often occurs in patients with certain systemic disorders, and pathologists should carefully consider the disease background of patients with repeated pneumothorax. Especially in middle-aged women and/or patients with a family history of pneumothorax, lymphangioleiomyomatosis, endometriosis, and some genetic disorders such as a-antitrypsin deficiency and Marfan syndrome are included in the differential diagnosis. Thoracic CT greatly contributes to the diagnosis of BHD syndrome. 25 Bilaterally located cysts in the medial and subpleural regions of the lungs suggest underlying systemic disorders.
Contrary to what is known about the radiologic findings in BHD lungs, there is a paucity of detailed information about the microscopic features of pulmonary cysts. In the present study, we demonstrated the following: (1) BHD pulmonary cysts represent initial cystic alveolar expansion partially incorporated within the visceral pleura, interlobular septa, or bronchovascular bundles. Secondary changes such as repeated pneumothorax and mesothelial invagination often mask the original form. (2) The epithelial cells constituting the cysts have benign appearance, but they include type II pneumocyte-like cells showing pathologic activity and positive staining for PCNA and p-S6. (3) Carcinoma cells in the BHD kidney are frequently negative for FLCN expression, whereas the cyst-forming epithelial cells of the lung and the epithelia of renal cysts in tumor-free areas stain positively for FLCN. These results suggest that pulmonary and renal cysts of the BHD syndrome are FLCN haploinsufficient with subtle activation of mTORC1 but without overtly neoplastic behavior.
The present histopathologic study highlighted the diagnostic clues seen in BHD lungs. The BHD pulmonary cyst is neither a bullae/bleb nor a degenerative change; instead, it is very likely a slowly growing hamartomatous cyst that frequently ruptures. Small-sized cysts may occur silently without rupture; however, the typical manifestation of repeated pneumothorax indicates that some cysts subtly escape from physiological control and continuously expand. The pitfall for pathologic diagnosis includes the phenomenon that the wall of the cyst often becomes thickened secondary to rupture or mechanical stress during expansion. Such stimulation may alter the morphology of cyst walls, and in most cases bleb-like fibrotic walls with mesothelial invagination have been resected and considered to be the main lesion in the lung. Thus, we speculate that, even in previous reports of cases diagnosed with BHD syndrome-associated lungs, the pathology was often described as nonspecific bullae/blebs because of the presence of such lesions. 5, 6, 22 The histopathologic features presented here are important diagnostic clues when combined with the characteristic radiologic findings. 25 The organ-specific disorders of BHD patients manifested in the skin, kidney, and lung indicate that BHD syndrome can be categorized as an mTOR-associated hamartoma syndrome that clinically resembles tuberous sclerosis. 12 The molecular mechanism of tuberous sclerosis has been well characterized; the TSC1-TSC2 complex interacts with Rheb GPTase and negatively regulates mTORC1-mediated signaling. 13 In contrast, the role of FLCN in the mTOR pathway is not fully understood. Both positive and negative effects of FLCN on mTOR downstream have been seen in studies using different experimental designs and models. 2, 8, 11, 24 For example, an in vitro study found that p-S6 levels were decreased in a few cell lines treated with FLCN siRNA, 8 whereas an in vivo study found that p-mTOR and p-S6 levels were increased in renal cysts of kidney-targeted FLCN knockout mice. 2 Pulmonary cyst formation is the most frequent manifestation in BHD families. 23, 32 Little is known about the onset and molecular networks involved in cyst formation and rupture in human BHD patients. Sudden loss of FLCN is unlikely to occur in the early stage of BHD disorders. The functions of FLCN-interacting molecules might be affected in a spatiotemporal manner depending on the severity of FLCN dysfunction. In this study, immunostaining positive for p-S6 expression was observed in the majority of recognizable pulmonary cysts (Fig. 5D ) and in the dilated tubules/cysts of the kidney (data not shown). Although tissue microenvironments are different in the lung and kidney, similar cystic changes and increased p-S6 expression in BHD patients indicate the possible involvement of haploinsufficient FLCN in deranged epithelial-stromal interaction through mTOR signaling. It is well known that molecular cross-talk between the epithelium and mesenchyme plays an important role in the development and differentiation of lung tissue. 16, 29 The previous studies of renal tumors in BHD syndrome showed that the tumors are multifocal and predominantly consist of chromophobe renal cell carcinomas, hybrid oncocytic and chromophobe tumors, and oncocytoma. 20, 32 Such characteristic features within a background of oncocytosis may alert renal pathologists to the possibility of BHD syndrome. In this study, BHD renal tumors had morphologic features similar to those previously described; however, additional pathologic studies are needed to determine whether such histologic typing of BHD tumors is really accurate. BHD tumors showed severely reduced expression of mRNA FLCN, 30 supporting a correlation between neoplastic changes and FLCN dysfunction. In contrast, no mutation in FLCN has been found in sporadic chromophobe renal cell carcinomas and oncocytomas. 18, 21 Hierarchical clustering analysis of gene expression indicates that BHD renal tumors deviate from conventional renal tumors. 17 Correlation of FLCN dysfunction with detailed oncocytic morphology of BHD renal tumors is a subject for future study.
When diagnosed in advanced stages, renal tumors may determine the prognosis of BHD patients. In contrast, in most patients, pulmonary cysts do not directly affect the life span. Very limited information is currently available about the lung cancer rate in BHD patients. Indeed, pulmonary cysts have not been discussed with respect to tumorigenesis. However, it should be noted that lung adenocarcinomas and adenomas were reported in heterozygous FLCN knockout mice (BHD +/ À ). 8 Furthermore, a few cases of low-grade atypical adenomatous hyperplasia and adenocarcinoma of the lung were reported in BHD patients. 1, 7 Prospective study is needed of BHD patients and their family members and will improve our understanding of pulmonary cysts with respect to disease onset and time course of the changes.
Pulmonary cyst-induced pneumothorax is a hallmark sign that allows clinicians and pathologists to identify undiagnosed BHD families. 27 In BHD families, the frequency of pneumothorax is higher than that of renal tumors, and the onset of pneumothorax generally starts in younger individuals at 20 to 30 years of age. 7, 26, 32 If pathologists can correctly differentiate between cystic lesions in BHD lung from other airspace lesions, the number of BHD families who enter medical care may increase. Precise diagnosis of BHD pulmonary cysts will lead to periodic examinations for these patients, which will surely reduce the number of BHD pedigrees with advanced renal tumors. Characteristic BHD renal tumors, which include oncocytomas and hybrid tumors, are not aggressive compared with conventional clear cell carcinomas; however, BHD tumors may present with multifocal and bilateral lesions. 4 Therefore, it is very important to diagnose BHD syndrome and detect renal tumors at early stages so that patients can undergo nephron-sparing surgery, such as case 8 in our study.
In this report, we described the histopathologic features of BHD pulmonary cysts and showed that there was mild activation of mTORC1, suggesting that these cysts may be hamartoma-like lesions. We hope our data will be useful in providing improved understanding of the disease microenvironment and the correct pathologic diagnosis of BHD lung. The detailed mechanism of cyst formation should be further investigated. An additional subject for future study is whether cystic lesions in the BHD lung become neoplastic.
